ENvue Medical signs $50M equity facility; amends Series H preferred to add $59M

ENvue Medical, Inc.

Entered $50M committed equity facility; shares sold at 90% of 3-day VWAP.
40% of net proceeds to redeem Series X Preferred; remainder for working capital.
Second Amendment raises Series H Additional Investment Rights to $59M stated value ($53.1M subscription).
Investor commits to exercise at least $10M in 12 months post-shareholder approval, $833,333.33 monthly minimum.
Exchange cap of 1,858,403 shares (19.99% of outstanding) unless shareholder approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.